Skip to main content
Log in

Clinical trials review: Crystal deposition diseases

  • Clinical Trials Review
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

This review focuses on several recent clinically-related observations concerning Calcium Pyrophosphate Deposition Disease (CPPDD). Developments include new information on the epidemiology of idiopathic CPPDD in aging, on familial CPPDD, and on associated conditions that predispose to secondary CPPDD. Factors that may precipitate pseudogout, including the use of intra-articular hyaluronan and systemic G-CSF, are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Sanmarti R, Kanterewicz E, Pladevall M, et al.: Analysis of the association between chondrocalcinosis and osteoarthritis: a community based study. Am Rheum Dis 1996, 55:30–33.

    CAS  Google Scholar 

  2. Hughes AE, McGibbon D, Woodward E, et al.: Localisation of gene for chondrocalcinosis to chromosome 5p. Hum Mol Genet 1995, 4:1225–1228. An important advance in understanding familial CPPDD.

    Article  PubMed  CAS  Google Scholar 

  3. Baldwin CT, Farrer LA, Adair R, et al.: Linkage of early-onset osteoarthritis and chondrocalcinosis to human chromosome 8q. Am J Hum Genet 1995, 56:692–697. An important advance in understanding familial CPPDD.

    PubMed  CAS  Google Scholar 

  4. Smilde TJ, Haverman JF, Schipper P, et al.: Familial hypo-kalemia/ hypomagnesemia and chondrocalcinosis. J Rheumatol 1994, 21:1515–1519.

    PubMed  CAS  Google Scholar 

  5. Munoz-Fernandes S, Pantoja L, Martin Mola E, et al.: Chondro-calcinosis associated with Bartter’s syndrome and hypo-magnesemia. J Rheumatol 1994, 21:1782–1783.

    Google Scholar 

  6. Cobeta-Garcia JC, Gascon A, Iglesias E, et al.: Chondrocalcino-sis and Gitelman’s syndrome. A new association. Ann Rheum Dis 1998, 748–749.

  7. Hisakawa N, Yasuoka N, Itoh H, et al.: A case of Gitelman’s syn-drome with chondrocalcinosis. Endocr J 1998, 45:261–267.

    PubMed  CAS  Google Scholar 

  8. Gascon A, Cobeta-Garcia JC, Iglesias E: Gitelman syndrome and chondrocalcinosis. Nephrol Dial Transplant 1999, 14:515.

    Article  PubMed  CAS  Google Scholar 

  9. Punzi L, Calo L, Schiavon F, et al.: Chondrocalcinosis is a fea-ture of Gitelman’s variant of Bartter’s syndrome. A new look at the hypomagnesemia associated with calcium pyrophos-phate dihydrate crystal deposition disease. Rev Rheum Engl Ed 1998, 65:571–574.

    CAS  Google Scholar 

  10. Louthrenoo W, Sukitawut W: Calcium pyrophosphate dihy-drate crystal deposition: a clinical and laboratory analysis of 91 Thai patients. J Med Assoc Thai 1999, 82:569–576.

    PubMed  CAS  Google Scholar 

  11. Chaisson CE, McAlindon TE, Felson DT, et al.: Lack of associa-tion between thyroid status and chondrocalcinosis or osteoarthritis: the Framingham Osteoarthritis Study. J Rheumatol 1996, 23:711–715.

    PubMed  CAS  Google Scholar 

  12. Visinoni RA, Ferraz MB, Furlanetto RP, et al.: Hypothyroidism and chondrocalcinosis: new evidence for lack of association between the 2 pathologies. J Rheumatol 1993, 20:1991–1992.

    PubMed  CAS  Google Scholar 

  13. Gregoline PE, Peshoff ML, Trepal MJ: Gout and hypothyroid-ism. J Am Podiatr Med Assoc 1997, 87:394–396.

    PubMed  CAS  Google Scholar 

  14. Francois S, Guaydier-Souqieres G, Marcelli C: Acute sacroiliitis as a manifestation of calcium pyrophosphate dihydrate crystal deposition disease. A report of two cases. Rev Rheum Engl Ed 1997, 64:508–512.

    CAS  Google Scholar 

  15. Schlesinger N, Gowin KM, Baker DG, et al.: Acute gouty arthri-tis is seasonal. J Rheumatol 1998, 25:342–344.

    PubMed  CAS  Google Scholar 

  16. Sandor V, Hassan R, Kohn E: Exacerbation of pseudogout by granulocyte colony-stimulating factor. Ann Intern Med 1996, 125:781.

    PubMed  CAS  Google Scholar 

  17. Treamoto S, Yamamoto H, Ouchi Y: Increased synovial inter-leukin-8 and interleukin-6 levels in pseudogout associated with granulocyte colony-stimulating factor. Ann Intern Med 1998, 129:424–425.

    Google Scholar 

  18. Luzar MJ, Altawil B: Pseudogout following intraarticular injection of sodium hyaluronate. Arthritis Rheum 1998, 41:939–940.

    Article  PubMed  CAS  Google Scholar 

  19. Disla E, Infante R, Fahmy A, et al.: Recurrent acute calcium pyrophosphate dihydrate arthritis following intraarticular hyaluronate injection. Arthritis Rheum 1999, 42:1302–1303. References 18 and 19 are important clinical reports. Pseudogout after intraarticular hyaluronan can be recurrent.

    Article  PubMed  CAS  Google Scholar 

  20. Puttick MP, Wade JP, Chalmers A, et al.: Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 1995, 22:1311–1314.

    PubMed  CAS  Google Scholar 

  21. O’Hanolon D: Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 1996, 23:945–946.

    Google Scholar 

  22. Altman RD, Moskowitz R: Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 25:2203–2212.

  23. Marshall KW: Viscosupplementation for osteoarthritis: current status, unresolved issues, and future directions. J Rheumatol 1998, 25:2056–2058.

    PubMed  CAS  Google Scholar 

  24. Adams ME: Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 1996, 23:944–945.

    PubMed  CAS  Google Scholar 

  25. Prabhakar U, Lipshutz D, Truneh A: Inhibition of CD44, CD45 and LFA-3 mediated cytokine release from human monocytes by SK&F 86002 and pentoxifylline. Int J Immunopharmacol 1993, 15:205–209.

    Article  PubMed  CAS  Google Scholar 

  26. Webb DS, Shimizu Y, Van SeventerGA, et al.: LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 1990, 249:1295–1297.

    Article  PubMed  CAS  Google Scholar 

  27. McKee CM, Penno MB, Cowman M, et al.: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996, 98:2403–2313.

    PubMed  CAS  Google Scholar 

  28. Fujii K, Tanaka Y, Hubscher S, et al.: Cross-linking of CD44 on rheumatoid synovial cells up-regulates VCAM-1. J Immunol 1999, 162:2391–2398.

    PubMed  CAS  Google Scholar 

  29. Levesque MC, Haynes BF: TNF-a and IL-4 regulation of hyalu-ronan binding to monocyte CD44 involves posttranslational modification of CD44. Cell Immunol 1999, 193:209–218.

    Article  PubMed  CAS  Google Scholar 

  30. Levesque MC, Haynes BF: Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated pri-marily by TNF-a and is inhibited by IL-4 and IL-13. J Immunol 1997, 159:6184–6194.

    PubMed  CAS  Google Scholar 

  31. Mohamadzadeh M, DeGrendele H, Arizpe H, et al.: Proinflam-matory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest 1998, 101:97–108.

    Article  PubMed  CAS  Google Scholar 

  32. Malnick SD: Ariel-Ronen S, Evron E, et al.: Acute pseudogout as a complication of pamidronate. Ann Pharmacother 1997, 31:499–500.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terkeltaub, R.A. Clinical trials review: Crystal deposition diseases. Curr Rheumatol Rep 1, 97–100 (1999). https://doi.org/10.1007/s11926-999-0004-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-999-0004-6

Keywords

Navigation